Elevance Expands Myomo Coverage And Broadens Technology Enabled Care Story

Elevance Health has expanded its in-network coverage for Myomo’s FDA-cleared orthopedic devices to approximately 45 million members across its Commercial, Medicare Advantage, and Medicaid plans. This move strengthens Elevance’s position as a comprehensive health benefits and services provider, enhancing access to technology-enabled care without incurring manufacturing risks. The partnership aligns with Elevance’s focus on value-based care and digital tools, although potential cost pressures and execution risks need to be monitored.